Literature DB >> 33706806

Biotechnological Activities and Applications of Bacterial Pigments Violacein and Prodigiosin.

Seong Yeol Choi1, Sungbin Lim1, Kyoung-Hye Yoon2, Jin I Lee3, Robert J Mitchell4.   

Abstract

In this review, we discuss violacein and prodigiosin, two chromogenic bacterial secondary metabolites that have diverse biological activities. Although both compounds were "discovered" more than seven decades ago, interest into their biological applications has grown in the last two decades, particularly driven by their antimicrobial and anticancer properties. These topics will be discussed in the first half of this review. The latter half delves into the current efforts of groups to produce these two compounds. This includes in both their native bacterial hosts and heterogeneously in other bacterial hosts, including discussing some of the caveats related to the yields reported in the literature, and some of the synthetic biology techniques employed in this pursuit.

Entities:  

Keywords:  Antibacterial; Anticancer; Prodigiosin; Production; Secondary Metabolite; Synthetic Biology; Violacein

Year:  2021        PMID: 33706806      PMCID: PMC7948353          DOI: 10.1186/s13036-021-00262-9

Source DB:  PubMed          Journal:  J Biol Eng        ISSN: 1754-1611            Impact factor:   4.355


  160 in total

1.  Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein.

Authors:  André L Rodrigues; Nathalie Trachtmann; Judith Becker; Ananta F Lohanatha; Jana Blotenberg; Christoph J Bolten; Claudia Korneli; André O de Souza Lima; Luismar M Porto; Georg A Sprenger; Christoph Wittmann
Journal:  Metab Eng       Date:  2013-08-29       Impact factor: 9.783

2.  Synthesis, anion-binding properties, and in vitro anticancer activity of prodigiosin analogues.

Authors:  Jonathan L Sessler; Leah R Eller; Won-Seob Cho; Sergios Nicolaou; Apolonio Aguilar; Jeong Tae Lee; Vincent M Lynch; Darren J Magda
Journal:  Angew Chem Int Ed Engl       Date:  2005-09-19       Impact factor: 15.336

3.  Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.

Authors:  S Ohkuma; T Sato; M Okamoto; H Matsuya; K Arai; T Kataoka; K Nagai; H H Wasserman
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  Pathology of the Pine Wilt Disease Caused by Bursaphelenchus xylophilus.

Authors:  Y Mamiya
Journal:  Annu Rev Phytopathol       Date:  1983-09       Impact factor: 13.078

5.  Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines.

Authors:  B Montaner; S Navarro; M Piqué; M Vilaseca; M Martinell; E Giralt; J Gil; R Pérez-Tomás
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.

Authors:  S B Han; S H Park; Y J Jeon; Y K Kim; H M Kim; K H Yang
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

7.  Role of methionine in biosynthesis of prodigiosin by Serratia marcescens.

Authors:  S M Qadri; R P Williams
Journal:  J Bacteriol       Date:  1973-12       Impact factor: 3.490

8.  Integrated constraints based analysis of an engineered violacein pathway in Escherichia coli.

Authors:  Selva Rupa Christinal Immanuel; Deepanwita Banerjee; Mayooreshwar P Rajankar; Anu Raghunathan
Journal:  Biosystems       Date:  2018-07-03       Impact factor: 1.973

9.  Prodigiosin production by Serratia marcescens UCP 1549 using renewable-resources as a low cost substrate.

Authors:  Helvia W Casullo de Araújo; K Fukushima; Galba M Campos Takaki
Journal:  Molecules       Date:  2010-10-08       Impact factor: 4.411

10.  Rationally reduced libraries for combinatorial pathway optimization minimizing experimental effort.

Authors:  Markus Jeschek; Daniel Gerngross; Sven Panke
Journal:  Nat Commun       Date:  2016-03-31       Impact factor: 14.919

View more
  6 in total

Review 1.  Multi-target drug with potential applications: violacein in the spotlight.

Authors:  Nelson Durán; Gerson Nakazato; Marcela Durán; Ignasio R Berti; Guillermo R Castro; Danijela Stanisic; Marcelo Brocchi; Wagner J Fávaro; Carmen V Ferreira-Halder; Giselle Z Justo; Ljubica Tasic
Journal:  World J Microbiol Biotechnol       Date:  2021-08-16       Impact factor: 3.312

2.  Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from Serratia marcescens ATCC 27117.

Authors:  Jelena Lazic; Sanja Skaro Bogojevic; Sandra Vojnovic; Ivana Aleksic; Dusan Milivojevic; Martin Kretzschmar; Tanja Gulder; Milos Petkovic; Jasmina Nikodinovic-Runic
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  Lignocellulosic substrates as starting materials for the production of bioactive biopigments.

Authors:  Tiago Daniel Madureira de Medeiros; Laurent Dufossé; Juliano Lemos Bicas
Journal:  Food Chem X       Date:  2022-01-22

Review 4.  Recent Advances in Prodigiosin as a Bioactive Compound in Nanocomposite Applications.

Authors:  Rafael G Araújo; Natalia Rodríguez Zavala; Carlos Castillo-Zacarías; Mario E Barocio; Enrique Hidalgo-Vázquez; Lizeth Parra-Arroyo; Jesús Alfredo Rodríguez-Hernández; María Adriana Martínez-Prado; Juan Eduardo Sosa-Hernández; Manuel Martínez-Ruiz; Wei Ning Chen; Damià Barceló; Hafiz M N Iqbal; Roberto Parra-Saldívar
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

5.  The Kiss of Death: Serratia marcescens Antibacterial Activities against Staphylococcus aureus Requires Both de novo Prodigiosin Synthesis and Direct Contact.

Authors:  Sungbin Lim; Jihun Bhak; Sungwon Jeon; Wonsik Mun; Jong Bhak; Seong Yeol Choi; Robert J Mitchell
Journal:  Microbiol Spectr       Date:  2022-04-18

Review 6.  Prodigiosin: a promising biomolecule with many potential biomedical applications.

Authors:  German A Islan; Boris Rodenak-Kladniew; Nehuen Noacco; Nelson Duran; Guillermo R Castro
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.